An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

If people leave oral thrush untreated, the candidiasis may travel to their esophagus or turn into something more serious ...

Hospitals are seeing an increase in Candida auris cases, putting more strain on healthcare systems to protect patients.

Cases of Candida auris, a dangerous, drug-resistant fungus, are rising in hospitals and senior care centers across the U.S.

Background: Invasive candidiasis is increasingly prevalent in premature infants and seriously ill children, and pediatric data on available antifungal therapies are lacking. Methods: We conducted ...

Candidiasis is the term for an infection from Candida yeast. Invasive candidiasis is an infection inside your body. It can impact internal organs or other parts of your body. Acute hematogenous ...

Fungal infections in India are rising, with growing resistance to treatment. Learn about common types, causes, drug ...

Candida auris is a species of fungus that can cause healthcare-associated invasive infections and outbreaks, posing a serious threat to global human health, according to Health Canada’s webpage ...

Furthermore, SCYNEXIS aims to restart the Phase 3 MARIO study for invasive candidiasis in Q2 2025, pending the FDA lifting a clinical hold. Financially, SCYNEXIS ended 2024 with $75.1 million in ...

The World Health Organization (WHO) this week published two reports spotlighting gaps in adequate medicines and diagnostic ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...